Tetsuya Eto

Tetsuya Eto

UNVERIFIED PROFILE

Are you Tetsuya Eto?   Register this Author

Register author
Tetsuya Eto

Tetsuya Eto

Publications by authors named "Tetsuya Eto"

Are you Tetsuya Eto?   Register this Author

100Publications

1737Reads

-Profile Views

Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma.

Ann Hematol 2019 May 7;98(5):1197-1207. Epub 2019 Feb 7.

Department of Pathology, Kurume University, School of Medicine, Asahimachi 67, Kurume, Fukuoka, 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03628-8DOI Listing
May 2019

Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 Apr 6. Epub 2019 Apr 6.

Department of Medicine and Biosystemic Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.04.006DOI Listing
April 2019

Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia.

Biol Blood Marrow Transplant 2019 Mar 8;25(3):436-442. Epub 2018 Oct 8.

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.10.002DOI Listing
March 2019

Hematopoietic Cell Transplantation for Acute Panmyelosis with Myelofibrosis: A Retrospective Study in Japan.

Biol Blood Marrow Transplant 2019 Jan 10;25(1):e23-e27. Epub 2018 Aug 10.

Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.08.006DOI Listing
January 2019

Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation.

Int J Hematol 2019 Jan 24;109(1):98-106. Epub 2018 Sep 24.

Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-Ku, Fukuoka, 810-8563, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-018-2538-8DOI Listing
January 2019

Impact of a Low CD34 Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation.

Biol Blood Marrow Transplant 2018 04 28;24(4):708-716. Epub 2017 Nov 28.

Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791173086
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2017.10.043DOI Listing
April 2018

Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older.

Biol Blood Marrow Transplant 2017 Dec 7;23(12):2079-2087. Epub 2017 Sep 7.

Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.09.003DOI Listing
December 2017

Clinicopathological features of primary splenic follicular lymphoma.

Ann Hematol 2017 Dec 3;96(12):2063-2070. Epub 2017 Oct 3.

Department of Pathology, School of Medicine, Kurume University, 67, Asahi-machi, Kurume, 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3139-yDOI Listing
December 2017

Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy.

Cancer Chemother Pharmacol 2017 Oct 18;80(4):807-813. Epub 2017 Aug 18.

Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3422-6DOI Listing
October 2017

Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma.

Br J Haematol 2017 09 11;178(5):719-727. Epub 2017 May 11.

Department of Pathology, Kurume University, School of Medicine, Kurume, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14736DOI Listing
September 2017

Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen.

Biol Blood Marrow Transplant 2017 Feb 11;23(2):300-309. Epub 2016 Nov 11.

Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.11.009DOI Listing
February 2017

Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.

Int J Hematol 2017 Jan 29;105(1):92-99. Epub 2016 Sep 29.

Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-016-2093-0DOI Listing
January 2017

Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis.

Exp Hematol 2016 09 13;44(9):817-825.e3. Epub 2016 May 13.

Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.05.001DOI Listing
September 2016

Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2016 09 21;22(9):1608-1614. Epub 2016 May 21.

Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Center for Cellular and Molecular Medicine, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.05.017DOI Listing
September 2016

Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study.

Br J Haematol 2015 Feb 17;168(3):463-6. Epub 2014 Sep 17.

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13124DOI Listing
February 2015

Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft-vs.-host disease in adult patients in Japan.

Clin Transplant 2014 Sep 17;28(9):980-9. Epub 2014 Jul 17.

Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Aichi, Japan.

View Article

Download full-text PDF

Source
http://bos.nj.bpc.baidu.com/v1/liter/b96ab213c438f38f029e778
Web Search
http://doi.wiley.com/10.1111/ctr.12405
Publisher Site
http://dx.doi.org/10.1111/ctr.12405DOI Listing
September 2014

Genetic variants in C5 and poor response to eculizumab.

N Engl J Med 2014 Feb;370(7):632-9

From Osaka University Graduate School of Medicine (J.N., M.Y., H.S., Y.K.) and World Premier International Immunology Frontier Research Center and Research Institute for Microbial Diseases, Osaka University, Suita (T.K.), Medical Research Institute and Hard Tissue Genome Research Center, Tokyo Medical and Dental University (S.H., J.I.), Tokyo Medical University (K.O.), and Alexion Pharma (M.H.), Tokyo, Tokai University School of Medicine, Isehara (K.A.), Fukushima Medical University, Fukushima (H.N., T.S.), Ichinomiya Municipal Hospital, Ichinomiya (K.K.), Hamanomachi Hospital, Fukuoka (T.E.), Yamaguchi Grand Medical Center, Hofu (T.T.), Niigata University Medical and Dental Hospital, Niigata (M.M.), Japanese Red Cross Takayama Hospital, Takayama (T.M.), and Iwate Prefectual Central Hospital, Morioka (Y.W.) - all in Japan; University of Buenos Aires, Buenos Aires (A.L.B., A.L.); and Alexion Pharmaceuticals, Cheshire, CT (L.L., K.J., P.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1311084DOI Listing
February 2014

Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study.

Int J Hematol 2013 Aug 17;98(2):206-13. Epub 2013 Jul 17.

Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-013-1399-4DOI Listing
August 2013

Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.

Int J Hematol 2012 Jul 1;96(1):94-100. Epub 2012 May 1.

Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-012-1087-9DOI Listing
July 2012